121123-17-9|Cefprozil hydrate|(6R,7R)-7-[[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(E)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrate|-范德生物科技公司

Cefprozil hydrate

NMR下载 COA and HPLC MSDS下载
names：
(6R,7R)-7-[[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(E)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrate
CAS号：
121123-17-9
MDL Number：
MF(分子式)： C18H21N3O6S MW(分子量)： 407.44
EINECS: Reaxys Number:
Pubchem ID: Brand:BIOFOUNT

货品编码	规格	纯度	价格 (¥)	现价(¥)	特价(¥)	库存描述	数量	总计 (¥)

大包装询价提供各种包装，敬请垂询
收藏商品商品点评加入购物车立即购买

快速询价

收起

你想询价的产品

*产品名称：

CAS号：

产品编号：

需求描述：

请准确填写您的联系方式，以便为您提供最好的服务。

*公司名称：

*电子邮箱：

联系人：

*电话：

*验证码：

询价

中文别名	Cefprozil hydrate
英文别名	Cefprozil hydrate;
CAS号	121123-17-9
Inchi	InChI=1S/C18H19N3O5S.H2O/c1-2-3-10-8-27-17-13(16(24)21(17)14(10)18(25)26)20-15(23)12(19)9-4-6-11(22)7-5-9;/h2-7,12-13,17,22H,8,19H2,1H3,(H,20,23)(H,25,26);1H2/b3-2+;/t12-,13-,17-;/m1./s1
InchiKey	ALYUMNAHLSSTOU-CIRGZYLNSA-N
分子式 Formula	C18H21N3O6S
分子量 Molecular Weight	407.44
溶解度Solubility
性状	Solid powder
储藏条件 Storage conditions	Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).

产品说明	Cefprozil hydrate(CAS:121123-17-9):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。
Introduction	Cefprozil hydrate is a broad-spectrum cephalosporin antibiotic.
Application1
Application2
Application3

警示图
危险性	Warning
危险性警示
安全声明
安全防护
备注

[1]Jerath N, Shetty G. Redefining the management of pediatric tonsillopharyngitis with cefprozil. Indian J Pediatr. 2007 Dec;74(12):1105-8. Review. PubMed PMID: 18174646.

[2]Anzueto A, Bishai WR, Pottumarthy S. Role of oral extended-spectrum cephems in the treatment of acute exacerbation of chronic bronchitis. Diagn Microbiol Infect Dis. 2007 Mar;57(3 Suppl):31S-38S. Review. PubMed PMID: 17349461.

[3] Pichichero ME. Use of selected cephalosporins in penicillin-allergic patients: a paradigm shift. Diagn Microbiol Infect Dis. 2007 Mar;57(3 Suppl):13S-18S. Review. PubMed PMID: 17349459.

[4] Sader HS, Jacobs MR, Fritsche TR. Review of the spectrum and potency of orally administered cephalosporins and amoxicillin/clavulanate. Diagn Microbiol Infect Dis. 2007 Mar;57(3 Suppl):5S-12S. Epub 2007 Feb 9. Review. PubMed PMID: 17292577.

[5] Pichichero ME. Cephalosporins can be prescribed safely for penicillin-allergic patients. J Fam Pract. 2006 Feb;55(2):106-12. Review. PubMed PMID: 16451776.

6: Casey JR. Treating acute otitis media post-PCV-7: judicious antibiotic therapy. Postgrad Med. 2005 Dec;118(6 Suppl Emerging):32-3, 24-31. doi: 10.3810/pgm.12.2005.suppl42.220. Review. PubMed PMID: 19667702.7: Rosen T. Update on treating uncomplicated skin and skin structure infections. J Drugs Dermatol. 2005 Nov-Dec;4(6 Suppl):s9-14. Review. PubMed PMID: 16300224.8: Brook I. Microbiology and antimicrobial management of sinusitis. J Laryngol Otol. 2005 Apr;119(4):251-8. Review. PubMed PMID: 15949076.9: Ladhani S, Garbash M. Staphylococcal skin infections in children: rational drug therapy recommendations. Paediatr Drugs. 2005;7(2):77-102. Review. PubMed PMID: 15871629.10: Pichichero ME, Casey JR. Acute otitis media: making sense of recent guidelines on antimicrobial treatment. J Fam Pract. 2005 Apr;54(4):313-22. Review. PubMed PMID: 15833221.1

对不起，暂无产品评价！

MSDS

SDS 1.0 中文

展开

SDS 1.0 英文

展开